BioInvent Announces Publication of Data in Leading Cancer Journal Immunity

Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
(NYSE: BINV) Delayed: 42.98 -0.03 (0.07%)
Previous Close $43.01    52 Week High
Open $43.10    52 Week Low
Day High $43.19    P/E N/A 
Day Low $42.94    EPS
Volume 26,610